PMH29- COST ANALYSIS OF OLANZAPINE VERSUS RISPERIDONE IN THE TREATMENT OF UNCONTROLLED SCHIZOPHRENIA
Sep 1, 2001, 00:00 AM
10.1046/j.1524-4733.2001.40202-215.x
https://www.valueinhealthjournal.com/article/S1098-3015(11)71372-9/fulltext
Section Title :
Section Order :
264
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71372-9&doi=10.1046/j.1524-4733.2001.40202-215.x